Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups

Creative Commons License

Hojsak I., Fabiano V., Pop T. L., Goulet O., Zuccotti G. V., Cokugras F. C., ...Daha Fazla

ACTA PAEDIATRICA, cilt.107, sa.6, ss.927-937, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 107 Sayı: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1111/apa.14270
  • Dergi Adı: ACTA PAEDIATRICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.927-937
  • Anahtar Kelimeler: Bifidobacterium, Children, Lactobacillus, Probiotics, Saccharomyces, INTERNATIONAL SCIENTIFIC ASSOCIATION, LACTOBACILLUS-RHAMNOSUS HN001, REUTERI DSM 17938, 1ST 6 MONTHS, DOUBLE-BLIND, PRIMARY PREVENTION, NOSOCOMIAL DIARRHEA, FOLLOW-UP, CONSENSUS STATEMENT, ALLERGIC DISEASE
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Aim: The use of probiotics has been covered by many guidelines, position papers and evidence-based recommendations, but few have referred to specific patient groups or clinical indications. This review summarises recommendations and scientifically credited guidelines on the use of probiotics for children with selected clinical conditions and provides practice points.